Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 3/2011

01.03.2011 | Article

Outcome of hospitalized MDR-TB patients: Israel 2000–2005

verfasst von: D. Bendayan, A. Hendler, V. Polansky, M. Weinberger

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

MDR-TB has emerged in Israel following an immigrations wave from the Former Soviet Union (FSU) and Ethiopia. The purpose of this study was to outline characteristics and outcome of hospitalized MDR-TB patients. We retrospectively summarized charts of MDR-TB patients hospitalized in the national referral tuberculosis centers from January 2000 to December 2005, and followed them for 2 years. One hundred thirty-two patients were identified with a median age of 40 years and male predominance (77%). The majority of the patients were immigrants from FSU (83%) and Ethiopia (7.6%). They were characterized by alcohol (25.8%) and IV drug abuse (23.5%), presented with advanced disease manifested by hypoalbuminemia (50.8%) and smear positivity (70.5%). Cure was achieved in 50.3% and 30.4% died. Factors independently associated with death were patients’ age (OR = 1.036 for each year, 95%CI 1.0–1.1, p = 0.014), hypoalbuminemia (OR = 2.95, 95%CI 1.1–7.6, p = 0.025), smear positivity at diagnosis (OR = 3.7, 95%CI 1.2–11.4, p = 0.023), alcohol abuse (OR = 4.8, 95%CI 1.7–13.7, p = 0.004) and XDR-TB resistance pattern (OR 8.3, 95%CI 1.5–44.6, p = 0.014). This study brings out the poor prognosis of a highly vulnerable immigration population. Efforts should be focused on earlier diagnosis and treatment in a well controlled hospital environment and to professional support groups to attend to this population’s special needs.
Literatur
1.
Zurück zum Zitat Zignol M, Hosseini MS, Wrigh A, Weezenbeck CL, Numn P, Watt CJ et al (2006) Global incidence of multidrug resistant tuberculosis. J Infect Dis 194:479–485CrossRefPubMed Zignol M, Hosseini MS, Wrigh A, Weezenbeck CL, Numn P, Watt CJ et al (2006) Global incidence of multidrug resistant tuberculosis. J Infect Dis 194:479–485CrossRefPubMed
2.
Zurück zum Zitat Sharma SK, Mohan A (2006) Multidrug resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 130:261–272CrossRefPubMed Sharma SK, Mohan A (2006) Multidrug resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 130:261–272CrossRefPubMed
3.
Zurück zum Zitat Mak A, Thomas A, Del Granado M, Zaleskis R, Mouzafarova N, Menzies D (2008) Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. AJRCCM 178:306–312 Mak A, Thomas A, Del Granado M, Zaleskis R, Mouzafarova N, Menzies D (2008) Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. AJRCCM 178:306–312
4.
Zurück zum Zitat World Health Organization (2008) Antituberculosis drug resistance in the world: the WHO IUATLD global project on antituberculosis drug resistance surveillance. WHO, Geneva World Health Organization (2008) Antituberculosis drug resistance in the world: the WHO IUATLD global project on antituberculosis drug resistance surveillance. WHO, Geneva
5.
Zurück zum Zitat Sosna J, Shulimzon T, Roznman J, Lidgi M, Lavy A, Ben Dov IZ et al (1999) Drug resistant pulmonary tuberculosis in Israel, a society of immigrants: 1985–1994. Int J Tuberc Lung Dis 3:689–694PubMed Sosna J, Shulimzon T, Roznman J, Lidgi M, Lavy A, Ben Dov IZ et al (1999) Drug resistant pulmonary tuberculosis in Israel, a society of immigrants: 1985–1994. Int J Tuberc Lung Dis 3:689–694PubMed
7.
Zurück zum Zitat Chemtob D, Leventhal A, Berlowitz D, Weiler-Ravell D (2003) The new national tuberculosis control programme in Israel, a country of high immigration. Int J Tuberc Lung Dis 7:828–836PubMed Chemtob D, Leventhal A, Berlowitz D, Weiler-Ravell D (2003) The new national tuberculosis control programme in Israel, a country of high immigration. Int J Tuberc Lung Dis 7:828–836PubMed
8.
Zurück zum Zitat Collins CH, Grange JM, Yates MD (1997) Drug susceptibility test, the RRM (resistance ratio method) in tuberculosis bacteriology: organization and practice, 2nd edn. Butterworths Heinimann, Oxford, pp 98–109 Collins CH, Grange JM, Yates MD (1997) Drug susceptibility test, the RRM (resistance ratio method) in tuberculosis bacteriology: organization and practice, 2nd edn. Butterworths Heinimann, Oxford, pp 98–109
9.
Zurück zum Zitat Lavy A, Mates A (1994) A 10 year survey on Mycobacterium tuberculosis isolates in Israel and their drug resistance. Isr J Med Sci 30:805–810PubMed Lavy A, Mates A (1994) A 10 year survey on Mycobacterium tuberculosis isolates in Israel and their drug resistance. Isr J Med Sci 30:805–810PubMed
10.
Zurück zum Zitat Yinnon AM, Sasson A, Schlesinger Y, Raveh D, Jerassi Z, Rudensky B (1997) Emergence of drug-resistant tuberculosis in Jerusalem: ten-year retrospective review. Isr J Med Sci 33:728–733PubMed Yinnon AM, Sasson A, Schlesinger Y, Raveh D, Jerassi Z, Rudensky B (1997) Emergence of drug-resistant tuberculosis in Jerusalem: ten-year retrospective review. Isr J Med Sci 33:728–733PubMed
11.
Zurück zum Zitat Gilad J, Borer A, Riesenberg K, Peled N, Schlaeffer F (2000) Epidemiology and ethnic distribution of multidrug-resistant tuberculosis in southern Israel, 1992-1997: the impact of immigration. Chest 117:738–743CrossRefPubMed Gilad J, Borer A, Riesenberg K, Peled N, Schlaeffer F (2000) Epidemiology and ethnic distribution of multidrug-resistant tuberculosis in southern Israel, 1992-1997: the impact of immigration. Chest 117:738–743CrossRefPubMed
12.
Zurück zum Zitat Chan ED, Laurel V, Strand MJ, Chan JF, Huynh ML, Goble M et al (2004) Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 169:1103–1109CrossRefPubMed Chan ED, Laurel V, Strand MJ, Chan JF, Huynh ML, Goble M et al (2004) Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 169:1103–1109CrossRefPubMed
13.
Zurück zum Zitat Leimane V, Riekstina V, Holtz T, Zarovska E, Skripconoka V, Thorpe LE et al (2005) Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: a retrospective study. Lancet 365:318–326PubMed Leimane V, Riekstina V, Holtz T, Zarovska E, Skripconoka V, Thorpe LE et al (2005) Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: a retrospective study. Lancet 365:318–326PubMed
14.
Zurück zum Zitat Garcia-Garcia ML, Ponce de Leon A, Jimenez-Corona ME, Jimenez-Corona A, Palacios-Martinez M, Balandrano-Campos S et al (2000) Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico. Arch Intern Med 160:630–636CrossRefPubMed Garcia-Garcia ML, Ponce de Leon A, Jimenez-Corona ME, Jimenez-Corona A, Palacios-Martinez M, Balandrano-Campos S et al (2000) Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico. Arch Intern Med 160:630–636CrossRefPubMed
15.
Zurück zum Zitat Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ et al (2008) Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 47:496–502CrossRefPubMed Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ et al (2008) Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 47:496–502CrossRefPubMed
16.
Zurück zum Zitat Palmero DJ, Ambroggi M, Brea A, De Lucas M, Fulgenzi A, Martinez D et al (2004) Treatment and follow up of HIV negative multidrug resistant tuberculosis patients in an infectious disease reference hospital, Buenos Aires, Argentina. Int J Tuberc Lung Dis 8(6):778–784PubMed Palmero DJ, Ambroggi M, Brea A, De Lucas M, Fulgenzi A, Martinez D et al (2004) Treatment and follow up of HIV negative multidrug resistant tuberculosis patients in an infectious disease reference hospital, Buenos Aires, Argentina. Int J Tuberc Lung Dis 8(6):778–784PubMed
17.
Zurück zum Zitat Masjedi MR, Tabarsi P, Chitsaz E, Baghaesi P, Mirsaeidi M, Amiri MV et al (2008) Outcome of treatment of MDR-TB patients with standardized regimen, Iran, 2002-2006. Int J Tuberc Lung Dis 12:750–755PubMed Masjedi MR, Tabarsi P, Chitsaz E, Baghaesi P, Mirsaeidi M, Amiri MV et al (2008) Outcome of treatment of MDR-TB patients with standardized regimen, Iran, 2002-2006. Int J Tuberc Lung Dis 12:750–755PubMed
18.
Zurück zum Zitat Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R et al (2008) Multidrug and extensively drug resistant tuberculosis, Germany. Emerg Infect Dis 14:1700–1706CrossRefPubMed Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R et al (2008) Multidrug and extensively drug resistant tuberculosis, Germany. Emerg Infect Dis 14:1700–1706CrossRefPubMed
19.
Zurück zum Zitat Faustini A, Hall AJ, Perucci CA (2006) Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 61:158–163CrossRefPubMed Faustini A, Hall AJ, Perucci CA (2006) Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 61:158–163CrossRefPubMed
20.
Zurück zum Zitat Chan ED, Laurel V, Strand MJ, Chan JF, Huynh MLN, Goble M, Iseman MD (2004) Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. AJRCCM 169:1103–1109 Chan ED, Laurel V, Strand MJ, Chan JF, Huynh MLN, Goble M, Iseman MD (2004) Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. AJRCCM 169:1103–1109
21.
Zurück zum Zitat Shin SS, Pasechnikov AD, Gelmanova Y, Peremitin GG, Strelis AK, Andreev YG et al (2006) Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis 10:402–408PubMed Shin SS, Pasechnikov AD, Gelmanova Y, Peremitin GG, Strelis AK, Andreev YG et al (2006) Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis 10:402–408PubMed
22.
Zurück zum Zitat Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD (1995) Long-term survival following bacteremia or fungemia. JAMA 274:807–812CrossRefPubMed Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD (1995) Long-term survival following bacteremia or fungemia. JAMA 274:807–812CrossRefPubMed
23.
Zurück zum Zitat Weinberger M, Leibovici L, Perez S, Samra Z, Ostfeld I, Levi I et al (2005) Characteristics of candidaemia with Candida albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect 61:146–154CrossRefPubMed Weinberger M, Leibovici L, Perez S, Samra Z, Ostfeld I, Levi I et al (2005) Characteristics of candidaemia with Candida albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect 61:146–154CrossRefPubMed
24.
Zurück zum Zitat Koromath FS, Sumarmi HAG (2008) Infectious disease pattern and serum albumin levels in elderly people hospitalized at Dr. Moewardi Hospital Surakarta during 2004. Acta Med Indones 40(3):114–116PubMed Koromath FS, Sumarmi HAG (2008) Infectious disease pattern and serum albumin levels in elderly people hospitalized at Dr. Moewardi Hospital Surakarta during 2004. Acta Med Indones 40(3):114–116PubMed
25.
Zurück zum Zitat Numeroso F, Barilli AL, Delsignore R (2008) Prevalence and significance of hypoalbuminemia in an internal medicine department. Eur J Intern Med 19(8):587–591CrossRefPubMed Numeroso F, Barilli AL, Delsignore R (2008) Prevalence and significance of hypoalbuminemia in an internal medicine department. Eur J Intern Med 19(8):587–591CrossRefPubMed
26.
Zurück zum Zitat Lonnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C (2008) Alcohol use as a risk factor for tuberculosis—A systematic review. BMC Public Health 8:89–302CrossRef Lonnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C (2008) Alcohol use as a risk factor for tuberculosis—A systematic review. BMC Public Health 8:89–302CrossRef
27.
Zurück zum Zitat Rehm J, Samolhvalov AV, Neuman MG, Room R, Parry C, Lonroth K et al (2009) The association between alcohol use, alcohol use disorders and tuberculosis. A systematic review. BMC Public Health 9:450CrossRefPubMed Rehm J, Samolhvalov AV, Neuman MG, Room R, Parry C, Lonroth K et al (2009) The association between alcohol use, alcohol use disorders and tuberculosis. A systematic review. BMC Public Health 9:450CrossRefPubMed
28.
Zurück zum Zitat Moadebi S, Harder CK, Fitzgerald MJ, Elwood KR, Marra F (2007) Fluoroquinolones for the treatment ofpulmonary tuberculosis. Drugs 67:2077–2099CrossRefPubMed Moadebi S, Harder CK, Fitzgerald MJ, Elwood KR, Marra F (2007) Fluoroquinolones for the treatment ofpulmonary tuberculosis. Drugs 67:2077–2099CrossRefPubMed
29.
Zurück zum Zitat Ziganshina LE, Squire SB (2008) Fluoroquinolones for treating tuberculosis. Cochrane Database Syst Rev: CD004795 Ziganshina LE, Squire SB (2008) Fluoroquinolones for treating tuberculosis. Cochrane Database Syst Rev: CD004795
30.
Zurück zum Zitat Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K et al (2008) Fluoroquinolones: are they essential to treat multi drug resistant tuberculosis? Eur Respir J 31:904–905CrossRefPubMed Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K et al (2008) Fluoroquinolones: are they essential to treat multi drug resistant tuberculosis? Eur Respir J 31:904–905CrossRefPubMed
31.
Zurück zum Zitat Migliori GB, Lange C, Centis R, Sotgiu G, Mutterlein R, Hoffmann H et al (2008) Resistance to second-line injectable and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. Eur Respir J 31:1155–1159CrossRefPubMed Migliori GB, Lange C, Centis R, Sotgiu G, Mutterlein R, Hoffmann H et al (2008) Resistance to second-line injectable and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. Eur Respir J 31:1155–1159CrossRefPubMed
Metadaten
Titel
Outcome of hospitalized MDR-TB patients: Israel 2000–2005
verfasst von
D. Bendayan
A. Hendler
V. Polansky
M. Weinberger
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 3/2011
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-1096-7

Weitere Artikel der Ausgabe 3/2011

European Journal of Clinical Microbiology & Infectious Diseases 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.